Blue Trust’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
Blue Trust's IART Position: Q3 2026 in Review
Blue Trust reduced its Integra LifeSciences (IART) stake by 40% in Q3 2026, selling an estimated $12.2K and leaving 1,057 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1557.
Blue Trust first reported a position in IART in Q2 2022 and has held it in 18 quarters since. The position peaked at $113K in Q1 2023. 197 funds tracked by Wall St. Rank hold IART as of Q3 2026.
- Blue Trust held 1,057 shares of Integra LifeSciences worth $17.2K as of Q3 2026.
- Blue Trust sold 708 Integra LifeSciences shares in Q3 2026, an estimated $12.2K.
- Integra LifeSciences made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1557 holding.
- Blue Trust first reported a position in Integra LifeSciences in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Integra LifeSciences position peaked at $113K in Q1 2023.
- 197 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.